Pictet Asset Management Holding Sa Travere Therapeutics, Inc. Transaction History
Pictet Asset Management Holding Sa
- $93.5 Billion
- Q2 2025
A detailed history of Pictet Asset Management Holding Sa transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 595,681 shares of TVTX stock, worth $16.4 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
595,681
Previous 665,570
10.5%
Holding current value
$16.4 Million
Previous $11.9 Million
26.08%
% of portfolio
0.01%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding TVTX
# of Institutions
230Shares Held
101MCall Options Held
1.71MPut Options Held
401K-
Janus Henderson Group PLC London, X09.54MShares$262 Million0.07% of portfolio
-
Armistice Capital, LLC New York, NY8.88MShares$244 Million2.3% of portfolio
-
Black Rock Inc. New York, NY7.64MShares$210 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.99MShares$165 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C35.1MShares$140 Million0.1% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $1.77B
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...